Frequency Therapeutics
Lexington · Founded 2015
About Frequency Therapeutics
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $180.3M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2022)
- Ticker: nasdaq:FREQ
- Website: http://www.frequencytx.com/index.php
- Phone: 866-389-1970
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/frequency-therapeutics-115847 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.